Found 14 matching trials
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects PHASE1 The main purpose of the study is to understand the safety and tolerability ...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA) PHASE2 Lenalidomide is a standard of care for maintenance therapy after autologous...
Show More Learn More & Join Trial
Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma PHASE2 A phase II study of single agent elranatamab in patients with relapsed and/...
Show More Location
Vancouver Cancer Center
Learn More & Join Trial
Elranatamab in R/R Multiple Myeloma PHASE2 This research is being done to see if the study drug, elranatamab, reduces ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes PHASE2 The goal of this phase II, open-label, single-arm, multicenter study is to ...
Show More Status
Active Not Recruiting
Location
Hospital Clínico Universitario de Santiago ~ CHUS
Learn More & Join Trial
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies PHASE1 A Phase 1/2a study to assess the safety, tolerability, PK and biological ac...
Show More Location
Emory Winship Cancer Institute
Learn More & Join Trial
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) PHASE1 The purpose of the study is to evaluate safety and tolerability of the comb...
Show More Location
Royal Prince Alfred Hospital
Learn More & Join Trial
ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma PHASE2 This research study is being done to compare the efficacy and safety of the...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Safety and Efficacy of Elranatamab Plus Isatuximab, Bortezomib, and Lenalidomide in Ultra-High-Risk Multiple Myeloma PHASE2 This is a prospective, single-arm, single-center interventional study desig...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments PHASE3 The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bis...
Show More Location
Clovis Community Medical Center
Learn More & Join Trial